SAN FRANCISCO, Nov. 28 – Reaction to Incyte Genomics’ Monday announcement appointing a new CEO and president, a move that underscores Incyte's intent to move from a genomics database provider to a drug developer, has been positive but also “wait and see.”

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Cancer researcher Alan Rabson has died at 92, the New York Times reports.

As the National Guideline Clearinghouse goes dark, the ECRI Institute says it will pick up the slack.

In Genome Research this week: sequencing method examines proteins parasite uses to evade immune system, L1 insertions in cancer, and more.

The Atlantic reports on private Facebook support groups for people who receive unexpected parentage results from direct-to-consumer genetic tests.